Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD

prnasiaJuly 07, 2021

Tag: Bionomics , BNC210 , PTSD , ATTUNE

PharmaSources Customer Service